December 3, 2018
IntegriChain today announced its fall release of the ICyte Platform, uniquely integrating disparate payer, patient, and distribution data on a single insights platform. The fall release includes enhancements to IntegriChain Specialty Analytics, allowing specialty brand teams to overcome key challenges in patient access, improve the patient journey, and save patient days of therapy. The release also integrates IntegriChain Access Management into the ICyte Platform and offers powerful new payer financial visibility and reporting to increase the transparency and accuracy critical to gross-to-net (GTN) forecasting.
November 14, 2018
Solutions Principal Shivani Patel will conduct a workshop on “Retail Inventory and Pipeline Accruals” at the CBI GTN 2018 Conference. The GTN 2018 Conference delivers two days of sessions and workshops on strategic forecasting, accounting estimates, analytics, and financial reporting for life science companies, beginning November 15 at the Hilton Philadelphia at Penn’s Landing. Patel’s workshop will be on Thursday, November 15, at 2:45 pm.
October 31, 2018
Executive Director of Solutions, David Weiss, will speak on the key impact of generics and brand pricing decisions on government price reporting and future profitability and compliance, and he will review government payer trends that affect commercializing product at the scwish:pharma Conference, designed for pharmaceutical manufacturers seeking actionable guidance about major industry issues.
October 22, 2018
IntegriChain announced that its annual IntegriChain User Conference, beginning today in Savannah, broke attendance records with more than 160 participants, including seven IntegriChain ecosystem partners and nearly 20 industry speakers.
October 1, 2018
IntegriChain announces that Dave Weiss, Executive Director of Industry Solutions and industry expert on 340B analytics, will chair the 340B Track at the Medicaid Drug Rebate Program Summit (MDRP). The MDRP 340B track is slated for October 2 from 1:45 pm to 5:20 pm, and 340B sessions dominate this year’s MDRP agenda overall.
August 20, 2018
IntegriChain has tapped Gary Palgon, a 25-year life sciences and cloud-computing veteran, as Senior Vice President to lead IntegriChain’s Sales organization. Palgon was previously VP of Sales and Marketing at Liaison Technologies where he excelled at partnering with the life sciences industry in implementing enterprise-class patient and supply chain data management platforms.
February 1, 2018
IntegriChain today announced the acquisition of Medical Communication Technologies, Inc. (MCT). MCT is a top provider of government pricing and contracting software and services. IntegriChain will integrate MCT’s government pricing SaaS platform into its ICyte data platform, creating a best-in-class offering for bio/pharma manufacturers. This acquisition adds 35+ new brand and generic bio/pharma manufacturer customers to IntegriChain’s 100+ customer base and is the company’s second acquisition since entering its strategic partnership with Accel-KKR, a leading technology-focused private equity firm, in 2016.
January 29, 2018
BPO center scales bio/pharma payer analytics and contracting functions to meet today’s complex commercial and government market access challenges IntegriChain SOC compliance report available upon request Philadelphia, PA, January 29, 2018 – IntegriChain, a leading healthcare technology company delivering a comprehensive data and analytics platform covering all core elements of access—Market Access, Patient Access, and Distribution, today announced the opening of its new Access Management Operations center for claims adjudication. This new facility will house the industry’s leading contract operations offering for government and commercial rebate processing and chargeback reconciliation in Ambler, PA, a suburb of Philadelphia. Additionally, IntegriChain announced that its […]
July 12, 2017
IntegriChain announces that it has surpassed 100 bio/pharmaceutical manufacturer customers for its cloud-based platform. The Company has accelerated its customer acquisition activities, signing 19 new customers so far in 2017. To date, all top-10 and 16 of the top-20 bio/pharma manufacturers use IntegriChain solutions.
May 6, 2017
PharmaMetrics, an IntegriChain company and leading provider analytics and services to optimizing market access, today announced it has successfully completed a Service Organization Controls (SOC 1) examination of its system of controls for calculating manufacturer rebate payments.
